speb/financial-data huggingface dataset:
LA.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4954999.00
LA.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4954999.00
LA.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4954999.00
LA.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4954999.00
LA.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4954999.00
LA.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4954999.00
LA.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -620702.00
LA.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
LA.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
LA.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -620702.00
LA.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 77379846.00
LA.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1602338.00
LA.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 68313641.00
LA.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 4264418.00
LA.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4264418.00
LA.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -1406578.00
LA.V income_statement (quarterly, 2026-03-31) — Normalized Income: -2302507.00
LA.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -602560.00
LA.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2618644.00
LA.V income_statement (quarterly, 2026-03-31) — Operating Income: -635685.00
LA.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
LA.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29572668.00
LA.V balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 6842056.00
LA.V balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1548694.00
LA.V balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3526279.00
LA.V income_statement (quarterly, 2026-03-31) — Other Gand A: 430921.00
LA.V income_statement (quarterly, 2026-03-31) — Other Income Expense: -3698612.00
LA.V balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 8250000.00
LA.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1890727.00
LA.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1046120.00
LA.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 76796.00
LA.V balance_sheet (quarterly, 2026-03-31) — Payables: 500752.00
LA.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 633344.00
LA.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 151148.00
LA.V income_statement (quarterly, 2026-03-31) — Pretax Income: -4954999.00
LA.V cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1602338.00
LA.V balance_sheet (quarterly, 2026-03-31) — Receivables: 586673.00
LA.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 48717.00
LA.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 48717.00
LA.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
LA.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -43674261.00
LA.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 79251.00
LA.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 510172.00
LA.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 29572668.00
LA.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 79250.00
LA.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 76563641.00
LA.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 68313641.00
LA.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LA.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 104803911.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 87333761.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 17668195.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 76563641.00
LA.V income_statement (quarterly, 2026-03-31) — Total Expenses: 635685.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 28240270.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 85629846.00
LA.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 19160157.00
LA.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: -2652492.00
LA.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -2652492.00
LA.V balance_sheet (quarterly, 2026-03-31) — Working Capital: 10093952.00
LAB cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
LAB balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 43457000.00
LAB balance_sheet (annual, 2021-12-31) — Cash Equivalents: 5003000.00
LAB balance_sheet (annual, 2021-12-31) — Cash Financial: 23448000.00
LAB cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
LAB balance_sheet (annual, 2021-12-31) — Current Debt: 6838000.00
LAB cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
LAB cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 12000.00
LAB balance_sheet (annual, 2021-12-31) — Goodwill: 106379000.00
LAB balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 135563000.00
LAB cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 2085000.00
LAB cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
LAB cash_flow (annual, 2021-12-31) — Issuance Of Debt: 16838000.00
LAB balance_sheet (annual, 2021-12-31) — Line Of Credit: 6838000.00
LAB cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 10000000.00
LAB cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -501000.00
LAB balance_sheet (annual, 2021-12-31) — Net Debt: 42596000.00
LAB cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 9499000.00
LAB cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 1318000.00
LAB cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
LAB cash_flow (annual, 2021-12-31) — Operating Gains Losses: 21000.00
LAB balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 29184000.00
LAB income_statement (annual, 2021-12-31) — Other Special Charges: 9000.00
LAB balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 0.00
LAB cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
LAB balance_sheet (annual, 2021-12-31) — Prepaid Assets: 4470000.00
LAB balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
LAB cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 6838000.00
LAB balance_sheet (annual, 2021-12-31) — Total Tax Payable: 1411000.00
LAB income_statement (annual, 2022-12-31) — +Operating Expense: 139667000.00
LAB income_statement (annual, 2022-12-31) — +Total Revenue: 97948000.00
LAB balance_sheet (annual, 2022-12-31) — Accounts Payable: 7914000.00
LAB balance_sheet (annual, 2022-12-31) — Accounts Receivable: 17280000.00
LAB balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -29029000.00
LAB balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 847008000.00
LAB balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -592000.00
LAB cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 11528000.00
LAB cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 11528000.00
LAB cash_flow (annual, 2022-12-31) — Amortization Of Securities: -674000.00
LAB cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 3526000.00
LAB income_statement (annual, 2022-12-31) — Basic Average Shares: 78305000.00
LAB income_statement (annual, 2022-12-31) — Basic EPS: -2.43
LAB cash_flow (annual, 2022-12-31) — Beginning Cash Position: 29467000.00
LAB balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 43500000.00
LAB cash_flow (annual, 2022-12-31) — Capital Expenditure: -3825000.00
LAB balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 37763000.00
LAB balance_sheet (annual, 2022-12-31) — Capital Stock: 80000.00
LAB balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 81309000.00
LAB balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 165784000.00
LAB balance_sheet (annual, 2022-12-31) — Cash Equivalents: 53894000.00
LAB balance_sheet (annual, 2022-12-31) — Cash Financial: 27415000.00
LAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 230758000.00
LAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -88127000.00
LAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -89370000.00
LAB cash_flow (annual, 2022-12-31) — Change In Account Payable: -2776000.00
LAB cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 4113000.00
LAB cash_flow (annual, 2022-12-31) — Change In Inventory: -8470000.00
LAB cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -9091000.00
LAB cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -3467000.00
LAB cash_flow (annual, 2022-12-31) — Change In Payable: -2776000.00
LAB cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1337000.00
LAB cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 33000.00
LAB cash_flow (annual, 2022-12-31) — Change In Receivables: 1063000.00
LAB cash_flow (annual, 2022-12-31) — Change In Working Capital: -18595000.00
LAB cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 1063000.00
LAB cash_flow (annual, 2022-12-31) — Changes In Cash: 53261000.00
LAB balance_sheet (annual, 2022-12-31) — Common Stock: 80000.00
LAB balance_sheet (annual, 2022-12-31) — Common Stock Equity: -81467000.00
LAB cash_flow (annual, 2022-12-31) — Common Stock Payments: -563000.00
LAB balance_sheet (annual, 2022-12-31) — Construction In Progress: 1612000.00
LAB income_statement (annual, 2022-12-31) — Cost Of Revenue: 60897000.00
LAB balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 10189000.00
LAB balance_sheet (annual, 2022-12-31) — Current Assets: 208815000.00
LAB balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3682000.00
LAB balance_sheet (annual, 2022-12-31) — Current Debt: 2083000.00
LAB balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5765000.00
LAB balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 14436000.00
LAB balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 14436000.00
LAB balance_sheet (annual, 2022-12-31) — Current Liabilities: 43443000.00
LAB cash_flow (annual, 2022-12-31) — Depreciation: 3499000.00
LAB cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 15027000.00
LAB cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 15027000.00
LAB income_statement (annual, 2022-12-31) — Diluted Average Shares: 78305000.00
LAB income_statement (annual, 2022-12-31) — Diluted EPS: -2.43
LAB income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -190098000.00
LAB income_statement (annual, 2022-12-31) — EBIT: -188597000.00
LAB income_statement (annual, 2022-12-31) — EBITDA: -173570000.00
LAB cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -404000.00
LAB cash_flow (annual, 2022-12-31) — End Cash Position: 82324000.00
LAB cash_flow (annual, 2022-12-31) — Financing Cash Flow: 230758000.00
LAB balance_sheet (annual, 2022-12-31) — Finished Goods: 15245000.00
LAB cash_flow (annual, 2022-12-31) — Free Cash Flow: -93195000.00
LAB cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 60081000.00
LAB cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 13719000.00
LAB income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -60081000.00
LAB balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1896000.00
LAB balance_sheet (annual, 2022-12-31) — Goodwill: 106251000.00
LAB balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 118851000.00
LAB balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 17872000.00
LAB balance_sheet (annual, 2022-12-31) — Gross PPE: 88564000.00
LAB income_statement (annual, 2022-12-31) — Gross Profit: 37051000.00
LAB cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 309000.00
LAB income_statement (annual, 2022-12-31) — Interest Expense: 4331000.00
LAB income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4331000.00
LAB income_statement (annual, 2022-12-31) — Interest Income: 2226000.00
LAB income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2226000.00
LAB cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 3493000.00
LAB balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -11583000.00
LAB balance_sheet (annual, 2022-12-31) — Inventory: 21473000.00
LAB balance_sheet (annual, 2022-12-31) — Invested Capital: -16575000.00
LAB cash_flow (annual, 2022-12-31) — Investing Cash Flow: -88127000.00
LAB cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 225000000.00
LAB cash_flow (annual, 2022-12-31) — Issuance Of Debt: 25000000.00
LAB balance_sheet (annual, 2022-12-31) — Leases: 12234000.00
LAB balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
LAB balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 34081000.00
LAB balance_sheet (annual, 2022-12-31) — Long Term Debt: 62809000.00
LAB balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 96890000.00
LAB cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 25000000.00
LAB cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
LAB balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 7506000.00
LAB cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
LAB cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -563000.00
LAB income_statement (annual, 2022-12-31) — Net Income: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -190098000.00
LAB cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -190098000.00
LAB income_statement (annual, 2022-12-31) — Net Interest Income: -2105000.00
LAB cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -84302000.00
LAB cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 18162000.00
LAB cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 25000000.00
LAB income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2105000.00
LAB cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -12758000.00
LAB balance_sheet (annual, 2022-12-31) — Net PPE: 59535000.00
LAB cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -3825000.00
LAB cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 225000000.00
LAB cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -6838000.00
LAB balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -200318000.00
LAB balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 19230000.00
LAB balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 18175000.00
LAB balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1055000.00
LAB income_statement (annual, 2022-12-31) — Normalized EBITDA: -99900000.00
LAB income_statement (annual, 2022-12-31) — Normalized Income: -117533050.00
LAB cash_flow (annual, 2022-12-31) — Operating Cash Flow: -89370000.00
LAB cash_flow (annual, 2022-12-31) — Operating Gains Losses: 73800000.00
LAB income_statement (annual, 2022-12-31) — Operating Income: -102616000.00
LAB income_statement (annual, 2022-12-31) — Operating Revenue: 96166000.00
LAB balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 79482000.00
LAB balance_sheet (annual, 2022-12-31) — Other Current Assets: 4278000.00
LAB balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2083000.00
LAB balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1896000.00
LAB income_statement (annual, 2022-12-31) — Other Income Expense: -88207000.00
LAB balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 12600000.00
LAB cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4890000.00
LAB balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3109000.00
LAB balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 961000.00
LAB income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -14537000.00
LAB balance_sheet (annual, 2022-12-31) — Other Properties: 67212000.00
LAB balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 84475000.00
LAB balance_sheet (annual, 2022-12-31) — Payables: 9088000.00
LAB balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 19277000.00
LAB balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3965000.00
LAB balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 311253000.00
LAB balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
LAB cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 225000000.00
LAB income_statement (annual, 2022-12-31) — Pretax Income: -192928000.00
LAB cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 917000.00
LAB balance_sheet (annual, 2022-12-31) — Properties: 0.00
LAB cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 7874000.00
LAB cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
LAB cash_flow (annual, 2022-12-31) — Purchase Of Investment: -137302000.00
LAB cash_flow (annual, 2022-12-31) — Purchase Of PPE: -3825000.00
LAB balance_sheet (annual, 2022-12-31) — Raw Materials: 16866000.00
LAB balance_sheet (annual, 2022-12-31) — Receivables: 17280000.00
LAB income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 60897000.00
LAB income_statement (annual, 2022-12-31) — Reconciled Depreciation: 15027000.00
LAB cash_flow (annual, 2022-12-31) — Repayment Of Debt: -6838000.00
LAB cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -563000.00
LAB income_statement (annual, 2022-12-31) — Research And Development: 37382000.00
LAB balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
LAB income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 13589000.00
LAB balance_sheet (annual, 2022-12-31) — Retained Earnings: -926096000.00
LAB cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
LAB cash_flow (annual, 2022-12-31) — Sale Of Investment: 53000000.00
LAB income_statement (annual, 2022-12-31) — Selling General And Administration: 102285000.00
LAB balance_sheet (annual, 2022-12-31) — Share Issued: 79904000.00
LAB cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
LAB cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -6838000.00
LAB income_statement (annual, 2022-12-31) — Special Income Charges: -13589000.00
LAB cash_flow (annual, 2022-12-31) — Stock Based Compensation: 14880000.00
LAB balance_sheet (annual, 2022-12-31) — Stockholders Equity: -81467000.00
LAB balance_sheet (annual, 2022-12-31) — Tangible Book Value: -200318000.00
LAB income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1105050.00
LAB income_statement (annual, 2022-12-31) — Tax Provision: -2830000.00
LAB income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.02
LAB balance_sheet (annual, 2022-12-31) — Total Assets: 390310000.00
LAB balance_sheet (annual, 2022-12-31) — Total Capitalization: -18658000.00
LAB balance_sheet (annual, 2022-12-31) — Total Debt: 102655000.00
LAB balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -81467000.00
LAB income_statement (annual, 2022-12-31) — Total Expenses: 200564000.00
LAB balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 471777000.00
LAB balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 181495000.00
LAB balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 428334000.00
LAB income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -116205000.00
LAB balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1174000.00
LAB income_statement (annual, 2022-12-31) — Total Unusual Items: -73670000.00
LAB income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -73670000.00
LAB balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 422000.00
LAB balance_sheet (annual, 2022-12-31) — Treasury Stock: 563000.00
LAB balance_sheet (annual, 2022-12-31) — Work In Process: 945000.00
LAB balance_sheet (annual, 2022-12-31) — Working Capital: 165372000.00
LAB income_statement (annual, 2023-12-31) — +Operating Expense: 113489000.00
LAB income_statement (annual, 2023-12-31) — +Total Revenue: 106340000.00
LAB balance_sheet (annual, 2023-12-31) — Accounts Payable: 9236000.00
LAB balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19660000.00
LAB balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -35489000.00
LAB balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 860816000.00
LAB balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -312000.00
LAB cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 11200000.00
LAB cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 11200000.00
LAB cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1261000.00
LAB cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
LAB income_statement (annual, 2023-12-31) — Basic Average Shares: 79160000.00
LAB income_statement (annual, 2023-12-31) — Basic EPS: -0.94
LAB cash_flow (annual, 2023-12-31) — Beginning Cash Position: 82324000.00
LAB cash_flow (annual, 2023-12-31) — Capital Expenditure: -2831000.00
LAB balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 34697000.00
LAB balance_sheet (annual, 2023-12-31) — Capital Stock: 83000.00
LAB balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 51704000.00
LAB balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 114895000.00
LAB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -6809000.00
LAB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 20237000.00
LAB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -43287000.00
LAB cash_flow (annual, 2023-12-31) — Change In Account Payable: 1618000.00
LAB cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 6183000.00
LAB cash_flow (annual, 2023-12-31) — Change In Inventory: -4914000.00
LAB cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3712000.00
LAB cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 884000.00
LAB cash_flow (annual, 2023-12-31) — Change In Payable: 1618000.00
LAB cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 7801000.00
LAB cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 862000.00
LAB cash_flow (annual, 2023-12-31) — Change In Receivables: -2893000.00
LAB cash_flow (annual, 2023-12-31) — Change In Working Capital: -1972000.00
LAB cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2991000.00
LAB cash_flow (annual, 2023-12-31) — Changes In Cash: -29859000.00
LAB balance_sheet (annual, 2023-12-31) — Common Stock: 83000.00
LAB balance_sheet (annual, 2023-12-31) — Common Stock Equity: -148051000.00
LAB cash_flow (annual, 2023-12-31) — Common Stock Payments: -5414000.00
LAB balance_sheet (annual, 2023-12-31) — Construction In Progress: 2334000.00
LAB income_statement (annual, 2023-12-31) — Cost Of Revenue: 55890000.00
LAB balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6626000.00
LAB balance_sheet (annual, 2023-12-31) — Current Assets: 158215000.00
LAB balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4323000.00
LAB balance_sheet (annual, 2023-12-31) — Current Debt: 59530000.00
LAB balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 63853000.00
LAB balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 16735000.00
LAB balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 16735000.00
LAB balance_sheet (annual, 2023-12-31) — Current Liabilities: 109327000.00
LAB cash_flow (annual, 2023-12-31) — Depreciation: 3980000.00
LAB cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 15180000.00
LAB cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 15180000.00
LAB income_statement (annual, 2023-12-31) — Diluted Average Shares: 79160000.00
LAB income_statement (annual, 2023-12-31) — Diluted EPS: -0.94
LAB income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -74656000.00
LAB income_statement (annual, 2023-12-31) — EBIT: -69637000.00
LAB income_statement (annual, 2023-12-31) — EBITDA: -54457000.00
LAB cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 34000.00
LAB cash_flow (annual, 2023-12-31) — End Cash Position: 52499000.00
LAB cash_flow (annual, 2023-12-31) — Financing Cash Flow: -6809000.00
LAB balance_sheet (annual, 2023-12-31) — Finished Goods: 8111000.00
LAB cash_flow (annual, 2023-12-31) — Free Cash Flow: -46118000.00
LAB cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
LAB balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2221000.00
LAB balance_sheet (annual, 2023-12-31) — Goodwill: 106317000.00
LAB balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 107717000.00
LAB balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 19972000.00
LAB balance_sheet (annual, 2023-12-31) — Gross PPE: 90339000.00
LAB income_statement (annual, 2023-12-31) — Gross Profit: 50450000.00
LAB cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 801000.00
LAB income_statement (annual, 2023-12-31) — Interest Expense: 4567000.00
LAB income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 4567000.00
LAB income_statement (annual, 2023-12-31) — Interest Income: 5572000.00
LAB income_statement (annual, 2023-12-31) — Interest Income Non Operating: 5572000.00
LAB cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3819000.00
LAB balance_sheet (annual, 2023-12-31) — Interest Payable: 0.00
LAB balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -7041000.00
LAB balance_sheet (annual, 2023-12-31) — Inventory: 20533000.00
LAB balance_sheet (annual, 2023-12-31) — Invested Capital: -84538000.00
LAB cash_flow (annual, 2023-12-31) — Investing Cash Flow: 20237000.00
LAB cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
LAB cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
LAB balance_sheet (annual, 2023-12-31) — Leases: 13785000.00
LAB balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 30374000.00
LAB balance_sheet (annual, 2023-12-31) — Long Term Debt: 3983000.00
LAB balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 34357000.00
LAB cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
LAB balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 7994000.00
LAB cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
LAB cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -5414000.00
LAB balance_sheet (annual, 2023-12-31) — Net Debt: 11809000.00
LAB income_statement (annual, 2023-12-31) — Net Income: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
LAB income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -74656000.00
LAB cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -74656000.00
LAB income_statement (annual, 2023-12-31) — Net Interest Income: 1005000.00
LAB cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 23068000.00
LAB cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2083000.00
LAB cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
LAB income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1005000.00
LAB cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -139000.00
LAB balance_sheet (annual, 2023-12-31) — Net PPE: 54850000.00
LAB cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2831000.00
LAB cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
LAB cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -2083000.00
LAB balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -255768000.00
LAB balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 15116000.00
LAB balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 14275000.00
LAB balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 841000.00
LAB income_statement (annual, 2023-12-31) — Normalized EBITDA: -40896000.00
LAB income_statement (annual, 2023-12-31) — Normalized Income: -63942810.00
LAB cash_flow (annual, 2023-12-31) — Operating Cash Flow: -43287000.00
LAB income_statement (annual, 2023-12-31) — Operating Income: -63039000.00
LAB income_statement (annual, 2023-12-31) — Operating Revenue: 106340000.00
LAB balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 80232000.00
LAB balance_sheet (annual, 2023-12-31) — Other Current Assets: 3127000.00
LAB balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 59530000.00
LAB balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2221000.00
LAB income_statement (annual, 2023-12-31) — Other Income Expense: -12170000.00
LAB balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1400000.00
LAB cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4803000.00
LAB balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2285000.00
LAB balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1065000.00
LAB income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1391000.00
LAB balance_sheet (annual, 2023-12-31) — Other Properties: 66226000.00
LAB balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 63191000.00
LAB balance_sheet (annual, 2023-12-31) — Payables: 10061000.00
LAB balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 16687000.00
LAB balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 12052000.00
LAB balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 311253000.00
LAB balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
LAB cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
LAB income_statement (annual, 2023-12-31) — Pretax Income: -74204000.00
LAB cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 827000.00
LAB balance_sheet (annual, 2023-12-31) — Properties: 0.00
LAB cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1496000.00
LAB cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
LAB cash_flow (annual, 2023-12-31) — Purchase Of Investment: -94896000.00
LAB cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2831000.00
LAB balance_sheet (annual, 2023-12-31) — Raw Materials: 12140000.00
LAB balance_sheet (annual, 2023-12-31) — Receivables: 19660000.00
LAB income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 55890000.00
LAB income_statement (annual, 2023-12-31) — Reconciled Depreciation: 15180000.00
LAB cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2083000.00
LAB cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -5414000.00
LAB income_statement (annual, 2023-12-31) — Research And Development: 25948000.00
LAB income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 13561000.00
LAB balance_sheet (annual, 2023-12-31) — Retained Earnings: -1000752000.00
LAB cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
LAB cash_flow (annual, 2023-12-31) — Sale Of Investment: 117964000.00
LAB income_statement (annual, 2023-12-31) — Selling General And Administration: 87541000.00
LAB balance_sheet (annual, 2023-12-31) — Share Issued: 83364000.00
LAB cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2083000.00
LAB income_statement (annual, 2023-12-31) — Special Income Charges: -13561000.00
LAB cash_flow (annual, 2023-12-31) — Stock Based Compensation: 13123000.00
LAB balance_sheet (annual, 2023-12-31) — Stockholders Equity: -148051000.00
LAB balance_sheet (annual, 2023-12-31) — Tangible Book Value: -255768000.00
LAB income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2847810.00
LAB income_statement (annual, 2023-12-31) — Tax Provision: 452000.00
LAB income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
LAB balance_sheet (annual, 2023-12-31) — Total Assets: 323067000.00
LAB balance_sheet (annual, 2023-12-31) — Total Capitalization: -144068000.00
LAB balance_sheet (annual, 2023-12-31) — Total Debt: 98210000.00
LAB balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -148051000.00
LAB income_statement (annual, 2023-12-31) — Total Expenses: 169379000.00
LAB balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 471118000.00
LAB balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 164852000.00
LAB balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 361791000.00
LAB income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -76600000.00
LAB balance_sheet (annual, 2023-12-31) — Total Tax Payable: 825000.00
LAB income_statement (annual, 2023-12-31) — Total Unusual Items: -13561000.00
LAB income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -13561000.00
LAB balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 3132000.00
LAB balance_sheet (annual, 2023-12-31) — Treasury Stock: 5977000.00
LAB cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
LAB balance_sheet (annual, 2023-12-31) — Work In Process: 282000.00
LAB balance_sheet (annual, 2023-12-31) — Working Capital: 48888000.00
LAB balance_sheet (quarterly, 2024-09-30) — Current Debt: 54913000.00
LAB balance_sheet (quarterly, 2024-09-30) — Goodwill: 106342000.00
LAB balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 129709000.00
LAB cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 60000.00
LAB cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
LAB cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
LAB cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 0.00
LAB balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 3388000.00
LAB balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 54913000.00
LAB balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 23367000.00
LAB balance_sheet (quarterly, 2024-09-30) — Other Receivables: 608000.00
LAB balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
LAB balance_sheet (quarterly, 2024-09-30) — Receivables Adjustments Allowances: -628000.00
LAB income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -3941000.00
LAB income_statement (annual, 2024-12-31) — +Operating Expense: 131889000.00
LAB income_statement (annual, 2024-12-31) — +Total Revenue: 91008000.00
LAB balance_sheet (annual, 2024-12-31) — Accounts Payable: 5049000.00
LAB balance_sheet (annual, 2024-12-31) — Accounts Receivable: 14741000.00
LAB balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -40265000.00
LAB balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1702219000.00
LAB balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -260000.00
LAB balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -260000.00
LAB cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 4346000.00
LAB cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 4346000.00
LAB cash_flow (annual, 2024-12-31) — Amortization Of Securities: -7435000.00
LAB cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
LAB balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 42963000.00
LAB balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 42963000.00
LAB income_statement (annual, 2024-12-31) — Basic Average Shares: 352670000.00
LAB income_statement (annual, 2024-12-31) — Basic EPS: -0.52
LAB cash_flow (annual, 2024-12-31) — Beginning Cash Position: 52499000.00
LAB cash_flow (annual, 2024-12-31) — Capital Expenditure: -8355000.00
LAB balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 30396000.00
LAB balance_sheet (annual, 2024-12-31) — Capital Stock: 396000.00
LAB balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 166728000.00
LAB balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 292874000.00
LAB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -102616000.00
LAB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 363174000.00
LAB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -143454000.00
LAB cash_flow (annual, 2024-12-31) — Change In Account Payable: -12975000.00
LAB cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 815000.00
LAB cash_flow (annual, 2024-12-31) — Change In Inventory: -9879000.00
LAB cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -10047000.00
LAB cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -4143000.00
LAB cash_flow (annual, 2024-12-31) — Change In Payable: -12975000.00
LAB cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -12160000.00
LAB cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1929000.00
LAB cash_flow (annual, 2024-12-31) — Change In Receivables: 8961000.00
LAB cash_flow (annual, 2024-12-31) — Change In Working Capital: -29197000.00
LAB cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 8967000.00
LAB cash_flow (annual, 2024-12-31) — Changes In Cash: 117104000.00
LAB balance_sheet (annual, 2024-12-31) — Common Stock: 396000.00
LAB balance_sheet (annual, 2024-12-31) — Common Stock Equity: 471722000.00
LAB cash_flow (annual, 2024-12-31) — Common Stock Payments: -40490000.00
LAB cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
LAB balance_sheet (annual, 2024-12-31) — Construction In Progress: 6028000.00
LAB income_statement (annual, 2024-12-31) — Cost Of Revenue: 46125000.00
LAB balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 9455000.00
LAB balance_sheet (annual, 2024-12-31) — Current Assets: 375883000.00
LAB balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 4806000.00
LAB balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4806000.00
LAB balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 15741000.00
LAB balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 15741000.00
LAB balance_sheet (annual, 2024-12-31) — Current Liabilities: 65895000.00
LAB cash_flow (annual, 2024-12-31) — Depreciation: 12515000.00
LAB cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 16861000.00
LAB cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 16861000.00
LAB income_statement (annual, 2024-12-31) — Diluted Average Shares: 352670000.00
LAB income_statement (annual, 2024-12-31) — Diluted EPS: -0.52
LAB income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -184899000.00
LAB income_statement (annual, 2024-12-31) — EBIT: -87081000.00
LAB income_statement (annual, 2024-12-31) — EBITDA: -70220000.00
LAB cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -785000.00
LAB cash_flow (annual, 2024-12-31) — End Cash Position: 168818000.00
LAB cash_flow (annual, 2024-12-31) — Financing Cash Flow: -102616000.00
LAB balance_sheet (annual, 2024-12-31) — Finished Goods: 7260000.00
LAB balance_sheet (quarterly, 2024-12-31) — Finished Goods: 7260000.00
LAB cash_flow (annual, 2024-12-31) — Free Cash Flow: -151809000.00
LAB cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -632000.00
LAB cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -158000.00
LAB balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1225000.00
LAB balance_sheet (annual, 2024-12-31) — Goodwill: 111297000.00
LAB balance_sheet (quarterly, 2024-12-31) — Goodwill: 111297000.00
LAB balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 140251000.00
LAB balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 140251000.00
LAB balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 15001000.00
LAB balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 15001000.00
LAB balance_sheet (annual, 2024-12-31) — Gross PPE: 89607000.00
LAB income_statement (annual, 2024-12-31) — Gross Profit: 44883000.00
LAB cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 607000.00
LAB cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 200000.00
LAB income_statement (annual, 2024-12-31) — Interest Expense: 3316000.00
LAB income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3316000.00
LAB income_statement (annual, 2024-12-31) — Interest Income: 20199000.00
LAB income_statement (annual, 2024-12-31) — Interest Income Non Operating: 20199000.00
LAB cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3088000.00
LAB balance_sheet (annual, 2024-12-31) — Interest Payable: 4262000.00
LAB balance_sheet (quarterly, 2024-12-31) — Interest Payable: 4262000.00
LAB balance_sheet (annual, 2024-12-31) — Inventory: 20744000.00
LAB balance_sheet (annual, 2024-12-31) — Invested Capital: 472021000.00
LAB cash_flow (annual, 2024-12-31) — Investing Cash Flow: 363174000.00
LAB balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
LAB balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
LAB cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
LAB cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
LAB balance_sheet (annual, 2024-12-31) — Leases: 13749000.00
LAB balance_sheet (annual, 2024-12-31) — Liabilities Heldfor Sale Non Current: 6779000.00
LAB balance_sheet (quarterly, 2024-12-31) — Liabilities Heldfor Sale Non Current: 6779000.00
LAB balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 25590000.00
LAB balance_sheet (annual, 2024-12-31) — Long Term Debt: 299000.00
LAB balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 25889000.00
LAB cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
LAB balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 7858000.00
LAB cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 278648000.00
LAB cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -40490000.00
LAB cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
LAB income_statement (annual, 2024-12-31) — Net Income: -138885000.00
LAB income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -184899000.00
LAB income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -90939000.00
LAB income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -47946000.00
LAB income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -138885000.00
LAB income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -90939000.00
LAB cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -138885000.00
LAB income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -138885000.00
LAB income_statement (annual, 2024-12-31) — Net Interest Income: 16883000.00
LAB cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 92881000.00
LAB cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -63192000.00
LAB cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -55000000.00
LAB cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
LAB cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 8192000.00
LAB income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 16883000.00
LAB cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1004000.00
LAB balance_sheet (annual, 2024-12-31) — Net PPE: 49342000.00
LAB cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8355000.00
LAB cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
LAB cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -63192000.00
LAB balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 471722000.00
LAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 138000.00
LAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 138000.00
LAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 40998000.00
LAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 39917000.00
LAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 138000.00
LAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 138000.00
LAB balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1081000.00
LAB income_statement (annual, 2024-12-31) — Normalized EBITDA: -54954000.00
LAB income_statement (annual, 2024-12-31) — Normalized Income: -78878860.00
LAB cash_flow (annual, 2024-12-31) — Operating Cash Flow: -143454000.00
LAB cash_flow (annual, 2024-12-31) — Operating Gains Losses: -632000.00
LAB income_statement (annual, 2024-12-31) — Operating Income: -87006000.00
LAB income_statement (annual, 2024-12-31) — Operating Revenue: 91008000.00
LAB balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 377530000.00
LAB balance_sheet (annual, 2024-12-31) — Other Current Assets: 4561000.00
LAB balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 20804000.00
LAB balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 20804000.00
LAB balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1225000.00
LAB income_statement (annual, 2024-12-31) — Other Income Expense: -20274000.00
LAB balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 28954000.00
LAB balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 28954000.00
LAB cash_flow (annual, 2024-12-31) — Other Non Cash Items: -18422000.00
LAB balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 186982000.00
LAB balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1062000.00
LAB income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -5008000.00
LAB balance_sheet (annual, 2024-12-31) — Other Properties: 61972000.00
LAB balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 126146000.00
LAB balance_sheet (annual, 2024-12-31) — Payables: 5049000.00
LAB balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 14504000.00
LAB balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10040000.00
LAB balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
LAB balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
LAB balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
LAB income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 46014000.00
LAB income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 0.00